Aspira Pathlab & Diagnostics informs about disclosure

19 Mar 2024 Evaluate
Aspira Pathlab & Diagnostics has informed that it enclosed the following disclosure Form - C pursuant to Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015 from Shraddha Bhanushali, Directors Immediate Relative of the Company for the acquisition of Equity Shares from the market as on March 18, 2024.

The above information is a part of company’s filings submitted to BSE. 

Aspira Pathlab&Diagn Share Price

67.68 0.93 (1.39%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Apollo Hospital Ent. 7189.25
Max Healthcare Inst 1097.95
Narayana Hrudayalay 1916.45
Aster DM Healthcare 635.10
Global Health 1163.75
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×